<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Cambridge Antibody Technology from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Cambridge Antibody Technology news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 12:13:03 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Cambridge+Antibody+Technology" rel="self" type="application/rss+xml" />

	
<item><title>ETEX Corporation Announces New Video Journal of Orthopaedics Release Featuring ETEX Technology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039980&amp;HITNO=0&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039980&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538504968%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039980&amp;HITNO=0&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039980&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538504968%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>CRT And AstraZeneca Form Major Alliance To Create Cancer Metabolism Drugs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039134&amp;HITNO=1&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039134&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537944146%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039134&amp;HITNO=1&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039134&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537944146%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Cancer leaves its (bio)mark</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032799&amp;HITNO=2&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032799&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534824171%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032799&amp;HITNO=2&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032799&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534824171%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery News:</description></item>
<item><title>Cancer Research Charity Signs AstraZeneca Discovery Pact</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038185&amp;HITNO=3&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038185&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537522297%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038185&amp;HITNO=3&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038185&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537522297%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Study: Single-cell imaging can identify gene interactions</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036536&amp;HITNO=4&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036536&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536649317%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036536&amp;HITNO=4&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036536&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536649317%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>HealthImaging:</description></item>
<item><title>Biogen reports higher profit, raises forecast</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035191&amp;HITNO=5&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035191&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536154643%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035191&amp;HITNO=5&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035191&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536154643%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MarketWatch:</description></item>
<item><title>CRT, AstraZeneca announce alliance to develop new anti-cancer drugs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033316&amp;HITNO=6&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033316&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535122849%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033316&amp;HITNO=6&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033316&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535122849%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>CRT and AstraZeneca form major alliance to create cancer metabolism drugs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033002&amp;HITNO=7&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033002&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534951817%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033002&amp;HITNO=7&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033002&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534951817%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cancer Research UK:</description></item>
<item><title>MedImmune, Inc. (formerly Cambridge Antibody Technology)-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027384&amp;HITNO=8&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027384&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532116041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027384&amp;HITNO=8&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027384&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532116041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>AstraZeneca Teams Up with CRT to Develop Drugs that Target Cancer Cell Metabolism</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030717&amp;HITNO=9&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030717&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533788562%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4030717&amp;HITNO=9&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4030717&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533788562%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Bid to find cancer tumours weakness</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028141&amp;HITNO=10&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028141&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532595058%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028141&amp;HITNO=10&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028141&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532595058%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Europe:</description></item>
<item><title>Genzyme Expands Framingham Campus (posted 02/05/10 at 11:38am)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027272&amp;HITNO=11&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027272&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532007160%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027272&amp;HITNO=11&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027272&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532007160%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>WBJournal.com:</description></item>
<item><title>Cambridge part of new cancer drug drive</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026875&amp;HITNO=12&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026875&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531461429%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026875&amp;HITNO=12&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026875&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2531461429%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Weekly UK:</description></item>
<item><title>Genzyme Expands Framingham Campus (posted Yesterday at 11:38am)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025062&amp;HITNO=13&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025062&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529399513%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025062&amp;HITNO=13&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025062&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529399513%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>WBJournal.com:</description></item>
<item><title>Genzyme Expands Framingham Campus (posted Today at 11:38am)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022342&amp;HITNO=14&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022342&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527609633%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022342&amp;HITNO=14&amp;MSIZE=261&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Cambridge%20Antibody%20Technology&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022342&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527609633%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>WBJournal.com:</description></item>
</channel></rss>